Physician profile
John Chan
NPI 1790185932
$4,805.52
in general payments reported to CMS, 2019-2025
18 companies · $820 in 2025
The $820 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $37.38 · 2021: $412 · 2022: $179 · 2023: $1,913 · 2024: $799 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,408 · Travel and Lodging: $981 · Entertainment: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,407.69 |
| Travel and Lodging | $981.28 |
| Entertainment | $142.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,255.04 | 2021-2025 | Precision7, Dailies, Precision 7 |
| Coopervision INC. | $283.09 | 2024-2025 | Clariti Contact Lens, Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $264.76 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $258.47 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $242.05 | 2019-2021 | |
| Optos, INC. | $162.70 | 2020-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $160.14 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $159.38 | 2021-2023 | Acuvue |
| Sight Sciences, INC. | $125.57 | 2023 | Tearcare System |
| Glaukos Corporation | $125.10 | 2025 | |
| Allergan, INC. | $124.99 | 2019 | |
| Bausch & Lomb Americas INC. | $123.90 | 2025 | Xiidra, Miebo |
| Sun Pharmaceutical Industries INC. | $121.81 | 2024 | |
| Apellis Pharmaceuticals, INC. | $121.81 | 2023 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $105.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $93.26 | 2019 | |
| Carl Zeiss Meditec, INC. | $60.36 | 2019 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.